Multiplexed immunofluorescent assays for CD4, CD8, CD20, CD138, IL-10 and BCL-6 were employed to visualise changes in immune infiltrate composition across NSCLC and with reference to those patients who developed post-operative recurrence. The gene discussed is BCL6; the disease is non-small cell lung carcinoma.